View Older Stories View More Recent Stories

Dec 8, 2025 04:57PM After-hours movers: NVIDIA, Toll Brothers, and more
Dec 8, 2025 02:15PM WAVE Life Sciences (WVE) PT Raised to $21 at Raymond James
Dec 8, 2025 01:20PM WAVE Life Sciences (WVE) PT Raised to $28 at Leerink Partners
Nov 10, 2025 04:04PM WAVE Life Sciences (WVE) PT Raised to $20 at Wedbush
Nov 3, 2025 10:00AM Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'
Oct 29, 2025 04:53PM Wave Life Sciences reports positive obesity trial results
Oct 27, 2025 07:17AM WAVE Life Sciences (WVE) Can Show Fat Mass Loss- Cantor Fitzgerald
Oct 14, 2025 04:23PM Clear Street Starts WAVE Life Sciences (WVE) at Buy, PT $22
Sep 3, 2025 08:40PM WAVE Life Sciences (WVE) PT Lowered to $16 at Jones Trading
Sep 3, 2025 01:18PM Raymond James on WAVE Life Sciences (WVE): 'We continue to view WVE’s wholly-owned gene-editing programs as more likely LT value drivers'
Sep 3, 2025 01:09PM WAVE Life Sciences (WVE) PT Raised to $26 at Leerink Partners
Sep 3, 2025 07:30AM Wave Life Sciences reports positive data from AATD drug trial
Aug 20, 2025 06:46AM Canaccord Genuity Reiterates Buy Rating on WAVE Life Sciences (WVE)
Aug 4, 2025 08:33AM Canaccord Genuity Starts WAVE Life Sciences (WVE) at Buy, 'making big waves in the RNA space'
Jul 30, 2025 07:54AM WAVE Life Sciences (WVE) Misses Q2 EPS by 4c
Jul 28, 2025 01:58AM Oppenheimer Starts WAVE Life Sciences (WVE) at Outperform
Jul 16, 2025 05:50AM Citi Starts WAVE Life Sciences (WVE) at Buy
Jul 11, 2025 07:01AM Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)
Jun 23, 2025 07:11AM Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)
Jun 23, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Jun 20, 2025 04:02PM Wave Life Sciences (WVE) Announces Oral Presentation of Preclinical Data Supporting WVE-007
Jun 17, 2025 02:48PM WAVE Life Sciences (WVE) 1100 contracts of January 10 calls trade as share price down 2.4%
May 28, 2025 08:01AM WAVE Life Sciences (WVE) Appoints Christopher Wright as Chief Medical Officer
May 12, 2025 06:59AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
May 8, 2025 07:45AM WAVE Life Sciences (WVE) Misses Q1 EPS by 4c
Apr 29, 2025 06:34AM Cantor Fitzgerald Starts WAVE Life Sciences (WVE) at Overweight
Apr 8, 2025 08:00AM Wedbush Starts WAVE Life Sciences (WVE) at Outperform
Mar 27, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Mar 26, 2025 09:43AM Jefferies Reiterates Buy Rating on WAVE Life Sciences (WVE)
Mar 26, 2025 07:31AM WAVE Life Sciences (WVE) Announces Positive Data from FORWARD-53 Clinical Trial in DMD
Mar 10, 2025 03:25PM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)
Mar 10, 2025 12:58PM Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)
Mar 6, 2025 07:00AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Mar 5, 2025 07:58AM Truist: 'WAVE Life Sciences (WVE) Remains One of Our Favorite Stocks for 2025'
Mar 4, 2025 12:08PM WAVE Life Sciences (WVE) PT Raised to $21 at JPMorgan
Mar 4, 2025 07:33AM WAVE Life Sciences (WVE) Tops Q4 EPS by 34c
Feb 25, 2025 05:04AM Jefferies Starts WAVE Life Sciences (WVE) at Buy
Feb 6, 2025 08:31AM WAVE Life Sciences (WVE) announces phase 1 of clinic trial of WVE-007
Dec 17, 2024 02:38PM WAVE Life Sciences (WVE) spreader of December 15 and 17.50 calls
Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks
Nov 12, 2024 10:31AM WAVE Life Sciences (WVE) PT Raised to $36 at Truist Securities
Oct 28, 2024 06:00AM Leerink Partners Reiterates Outperform Rating on WAVE Life Sciences (WVE)
Oct 21, 2024 06:46AM WAVE Life Sciences (WVE) PT Raised to $15 at RBC Capital
Oct 17, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Oct 16, 2024 04:09PM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)
Oct 16, 2024 08:52AM WAVE Life Sciences (WVE) Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
Oct 3, 2024 08:17AM WAVE Life Sciences (WVE) PT Raised to $19 at B.Riley
Sep 27, 2024 03:30AM JPMorgan Reinstates WAVE Life Sciences (WVE) at Overweight
Sep 26, 2024 06:04AM WAVE Life Sciences (WVE) Prices Upsized $200M Share and Warrant Offering
Sep 25, 2024 06:55AM Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)
View More Recent Stories View Older Stories